Kodiak Sciences/$KOD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kodiak Sciences
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Ticker
$KOD
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
113
ISIN
US50015M1099
Website
Kodiak Sciences Metrics
BasicAdvanced
$195M
-
-$3.62
2.43
-
Price and volume
Market cap
$195M
Beta
2.43
52-week high
$11.42
52-week low
$1.92
Average daily volume
353K
Financial strength
Current ratio
4.621
Quick ratio
4.497
Long term debt to equity
52.086
Total debt to equity
62.144
Profitability
EBITDA (TTM)
-181.257
Management effectiveness
Return on assets (TTM)
-34.10%
Return on equity (TTM)
-108.92%
Valuation
Price to book
1.79
Price to tangible book (TTM)
1.79
Price to free cash flow (TTM)
-1.813
Free cash flow yield (TTM)
-55.16%
Free cash flow per share (TTM)
-204.10%
Growth
Earnings per share change (TTM)
-18.38%
3-year earnings per share growth (CAGR)
-15.57%
What the Analysts think about Kodiak Sciences
Analyst ratings (Buy, Hold, Sell) for Kodiak Sciences stock.
Kodiak Sciences Financial Performance
Revenues and expenses
Kodiak Sciences Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kodiak Sciences stock?
Kodiak Sciences (KOD) has a market cap of $195M as of June 30, 2025.
What is the P/E ratio for Kodiak Sciences stock?
The price to earnings (P/E) ratio for Kodiak Sciences (KOD) stock is 0 as of June 30, 2025.
Does Kodiak Sciences stock pay dividends?
No, Kodiak Sciences (KOD) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Kodiak Sciences dividend payment date?
Kodiak Sciences (KOD) stock does not pay dividends to its shareholders.
What is the beta indicator for Kodiak Sciences?
Kodiak Sciences (KOD) has a beta rating of 2.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.